Comparison of the effects of pathogenic simian human immunodeficiency virus strains SHIV-89.6P and SHIV-KU2 in cynomolgus macaques

AIDS Research and Human Retroviruses

Volumn 24, Issue 4, 2008, Pages 643-654

  Pawar, Santosh N ^a,d,e   Mattila, Joshua T ^a   Sturgeon, Timothy J ^a   Lin, Philana Ling ^b   Narayan, Opendra ^c   Montelaro, Ronald C ^a   Flynn, JoAnne L ^a,f  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CENTRAL FLORIDA   (United States)

^e VaxDesign Corporation   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CHEMOKINE RECEPTOR; GAG PROTEIN; GAMMA INTERFERON; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL POPULATION; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY PARENCHYMA; LIVER; LUNG ALVEOLUS CELL; LUNG LAVAGE; LUNG PARENCHYMA; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MACACA; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN IMMUNODEFICIENCY VIRUS; SPLEEN; TUBERCULOSIS; VIRUS LOAD; VIRUS STRAIN;

ANIMALS; BRONCHOALVEOLAR LAVAGE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; HIV; INTERFERON TYPE II; LUNG; LYMPH NODES; MACACA FASCICULARIS; REASSORTANT VIRUSES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; VIRAL LOAD;

EID: 42449114492     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0238     Document Type: Article

References (28)

1. Selwyn PA, Hartel D, Lewis VA, et al.: A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-550.
2. Corbett EL, Watt CJ, Walker N, et al.: The growing burden of tuberculosis: Global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009-1021.
3. Lawn SD, Butera ST and Shinnick TM: Tuberculosis unleashed: The impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis. Microbes Infect 2002;4:635-646.
4. Hu SL: Non-human primate models for AIDS vaccine research. Curr Drug Targets Infect Disord 2005;5:193-201.
5. Nath BM, Schumann KE, and Boyer JD: The chimpanzee and other non-human-primate models in HIV-1 vaccine research. Trends Microbiol 2000;8:426-431.
6. Joag SV: Primate models of AIDS. Microbes Infect 2000;2:223-229.
7. Nishimura Y, Brown CR, Mattapallil JJ, et al.: Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques. Proc Natl Acad Sci USA 2005;102:8000-8005.
8. Barber SA, Gama L, Li M, et al.: Longitudinal analysis of simian immunodeficiency virus (SIV) replication in the lungs: Compartmentalized regulation of SIV. J Infect Dis 2006;194:931-938.
9. Sui Y, Li S, Pinson D, et al.: Simian human immunodeficiency virus-associated pneumonia correlates with increased expression of MCP-1, CXCL10, and viral RNA in the lungs of rhesus macaques. Am J Pathol 2005;166:355-365.
10. Capuano SV, Croix DA, Pawar S, et al.: Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect Immun 2003;71:5831-5844.
11. Walsh GP, Tan EV, de la Cruz EC, et al.: The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat Med 1996;2:430-436.
12. Joag SV, Li Z, Foresman L, et al.: Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques. AIDS Res Hum Retroviruses 1997;13:635-645.
13. Reimann KA, Li JT, Veazey R, et al.: A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J Virol 1996;70:6922-6928.
14. Leutenegger CM, Higgins J, Matthews TB, et al.: Real-time Taq-Man PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA. AIDS Res Hum Retroviruses 2001;17:243-251.
15. Cook RF, Cook SJ, Li FL, Montelaro RC, and Issel CJ: Development of a multiplex real-time reverse transcriptase-polymerase chain reaction for equine infectious anemia virus (EIAV). J Virol Methods 2002;105:171-179.
16. Lin PL, Pawar S, Myers A, et al.: Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect Immun 2006;74:3790-3803.
17. Reimann KA, Watson A, Dailey PJ, et al.: Viral burden and disease progression in rhesus monkeys infected with chimeric simianhuman immunodeficiency viruses. Virology 1999;256:15-21.
18. Pal R, Venzon D, Letvin NL, et al.: ALVAC-SIV-gag-pol-envbased vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J Virol 2002;76:292-302.
19. Reimann KA, Parker RA, Seaman MS, et al.: Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses. J Virol 2005;79:8878-8885.
20. Marcondes MC, Penedo MC, Lanigan C, et al.: Simian immunodeficiency virus-induced CD4+ T cell deficits in cytokine secretion profile are dependent on monkey origin. Viral Immunol 2006;19:679-689.
21. Beck JM: The immunocompromised host: HIV infection. Proc Am Thorac Soc 2005;2:423-427.
22. Habis A, Baskin GB, Murphey-Corb M, and Levy LS: Simian AIDS-associated lymphoma in rhesus and cynomolgus monkeys recapitulates the primary pathobiological features of AIDS-associated non-Hodgkin's lymphoma. AIDS Res Hum Retroviruses 1999;15:1389-1398.
23. Grivel JC, Elliott J, Lisco A, et al.: HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1. AIDS 2007;21:1263-1272.
24. Ayash-Rashkovsky M, Chenine AL, Steele LN, et al.: Coinfection with Schistosoma mansoni reactivates viremia in rhesus macaques with chronic simian-human immunodeficiency virus clade C infection. Infect Immun 2007;75:1751-1756.
25. Mathema B, Kurepina NE, Bifani PJ, and Kreiswirth BN: Molecular epidemiology of tuberculosis: Current insights. Clin Microbiol Rev 2006;19:658-685.
26. Sharma SK, Mohan A, Sharma A, and Mitra DK: Miliary tuberculosis: New insights into an old disease. Lancet Infect Dis 2005;5:415-430.
27. Hoffman TL, Stephens EB, Narayan O, and Doms RW: HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors. Proc Natl Acad Sci USA 1998;95:11360-11365.
28. Hoshino Y, Tse DB, Rochford G, et al.: Mycobacterium tuberculosis-induced CXCR4 and chemokine expression leads to preferential X4 HIV-1 replication in human macrophages. J Immunol 2004;172:6251-6258.